NIFTY
80.75  0.75% 		 10821.85
S&P BSE SENSEX
257.21  0.73% 		 35689.6
Divis Laboratories Ltd.
NSE : DIVISLAB BSE : 532488 ISIN code : INE361B01024
on 22-Jun-2018
NSE
-12    -1.14%
Rs. 1044.25
 
Days Low
Rs. 1035.05 		Days High
Rs. 1054.8

Open Rs. 1050.1
 
52 week Low
Rs. 605.75 		52 week High
Rs.1220
 
 
Bid :                 1044.30 (10)
Offer :        0.00 (0)
BSE
Rs.1044.30
-11.7    -1.11%
on 22-Jun-2018
BSE
-11.7    -1.11%
Rs. 1044.30
 
Days Low
Rs. 1033 		Days High
Rs. 1055.25

Open Rs. 1050.45
 
52 week Low
Rs. 611 		52 week High
Rs.1223
 
 
Bid :                 1044.30 (10)
Offer :        0.00 (0)
NSE
Rs.1044.25
-12    -1.14%
Summary Company Information Fund Holdings
Chart Display Advance Chart
Profit & Loss Balance Sheet Cash Flow Financial Ratios Quarterly Results
 
 
Last Price (Rs.)  1044.30 Value  17977085.00
Net Change (Rs.)  -11.70 Best Buy  1044.30
Volume  17250 Best Sell  0.00
Prev.Close (Rs.)  1056.00 Best Quantity  10
Open (Rs.)  1050.10 Sell Quantity  0
High (Rs.)  1054.80 52-Week High (Rs.)  1220.00
Low (Rs.)  1035.05 52-Week Low (Rs.)  605.75
Face Value (Rs.)  2 Market Cap.(Rs/ Mn)  277228.84
 
BSE
You need to upgrade your Flash Player
 
Financial (Rs .in Million)
Balance Sheet
Share Capital530.94 530.94 265.47 
Share Capital530.94 530.94 265.47 
Share Capital530.94 530.94 265.47 
Share Capital530.94 530.94 265.47 
Share Capital530.94 530.94 265.47 
Currents Investments16307.22 8028.52 7330.04 
More> 
 
Top 5 PeerCompanies * (Rs .in Million)
Company NameLTP* M.CapBVP/EDiv.Yield
Sun Pharma Inds. 576.30 1382731 82.40 0.00 0.35
Cipla 614.00 494387 175.28 50.67 0.49
Piramal Enterprises 2602.35 469965 1186.24 57.81 0.96
Cadila Healthcare 410.55 420298 75.66 63.51 0.85
Lupin 904.90 409126 349.13 13.01 0.55
 
Mutual Funds Holdings
 
Quarterly Result
(Rs .in millions)Mar 2018Dec 2017Sep 2017
Net Sales10879.5010378.808902.00
Operating Profit4346.703431.503107.90
PBDT4348.403428.903100.40
Net Profit2616.002246.602067.80
More> 
 
Company News
5/28/2018 12:00:00 AM
Board recommends Dividend
5/17/2018 12:00:00 AM
Infosys, Divis Laboratories and Zensar Technologies to see some action...
5/17/2018 12:00:00 AM
USFDA inspects Divis Laboratories’ facility at Telangana
More>
 
Ratios
   Earnings Per Share (Rs)39.68 
   Book NAV/Share(Rs)203.75 
   PAT Margin (%)25.91 
   Asset Turnover(x)0.73 
   PER(x)15.73 
   Yield(%)1.60 
   EV/Core EBITDA(x)10.92 
   M Cap / Sales4.12 
   Net Sales Growth(%)8.13 
   PAT Growth(%)-5.18 
   Total Debt/Equity(x)0.01 
   Current Ratio(x)6.16 
   Quick Ratio(x)4.24 
   Total Debt/Mcap(x)0.00 
More>
 
Privacy Statement  |  Disclaimer  |  Terms of Use   |  Careers  |  Feedback  |   Terms and Conditions  |  Anti Money Laundering Measures  |  Important Policies   |  Dos & Donts   |   BSE  |   NSE  |   SEBI NCDEX  |   NSDL  |   CDSL  |   RBI  |   AMFI  |   Ministry of Finance  |   Government of India
Copyright © 2012, Khandwala Securities Limited MAPIN UIN100012369, NSE INF2306000030, BSE INB010600030, NCDEX: NCDEX-CO-05-00506, AMFI ARN: 1673, Certificate of Registration as Portfolio Manager INP000000340, Certificate of Registration as Merchant Banking – INM000001899, SEBI Registration No. INB 230600030 (NSE) INB 010600030 (BSE)
For Investor Grievance please mail to: :investorgrievances@kslindia.com
CIN NO. : L67120MH1993PLC070709
Designed, Developed & Content Powered by  ● ● ● Accord Fintech Pvt. Ltd    Best viewed in internet Explorer 7.0 or above